Investing.com -- Jefferies initiated coverage of Jefferson Capital Inc with a Buy rating and a $29 price target, pointing to the company’s differentiated tech-based model, consistent financial ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...